Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6FT9

Crystal structure of CLK1 in complex with inhibitor 16

6FT9 の概要
エントリーDOI10.2210/pdb6ft9/pdb
分子名称Dual specificity protein kinase CLK1, 2-bromanyl-3-phenyl-1~{H}-pyrrolo[3,4-g]indol-8-one, BROMIDE ION, ... (7 entities in total)
機能のキーワードkinase, inhibitor, splicing kinase, clk, structural genomics, structural genomics consortium, sgc, transferase
由来する生物種Homo sapiens (Human)
細胞内の位置Nucleus: P49759
タンパク質・核酸の鎖数3
化学式量合計120774.08
構造登録者
主引用文献Walter, A.,Chaikuad, A.,Helmer, R.,Loaec, N.,Preu, L.,Ott, I.,Knapp, S.,Meijer, L.,Kunick, C.
Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
PLoS ONE, 13:e0196761-e0196761, 2018
Cited by
PubMed Abstract: Cdc2-like kinases (CLKs) represent a family of serine-threonine kinases involved in the regulation of splicing by phosphorylation of SR-proteins and other splicing factors. Although compounds acting against CLKs have been described, only a few show selectivity against dual-specificity tyrosine phosphorylation regulated-kinases (DYRKs). We here report a novel CLK inhibitor family based on a 6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one core scaffold. Within the series, 3-(3-chlorophenyl)-6,7-dihydropyrrolo[3,4-g]indol-8(1H)-one (KuWal151) was identified as inhibitor of CLK1, CLK2 and CLK4 with a high selectivity margin towards DYRK kinases. The compound displayed a potent antiproliferative activity in an array of cultured cancer cell lines. The X-ray structure analyses of three members of the new compound class co-crystallized with CLK proteins corroborated a molecular binding mode predicted by docking studies.
PubMed: 29723265
DOI: 10.1371/journal.pone.0196761
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.87 Å)
構造検証レポート
Validation report summary of 6ft9
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon